KATIE LLOYD: Open Payments
NPI 1457768483 · WEST SENECA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 52 payments from 14 companies in 2025. Trend: 2023 $659 · 2024 $648 · 2025 $1,445
Food & beverage: $1,091Education: $179Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $320 |
| Amgen Inc. | 8 | $318 |
| PFIZER INC. | 20 | $169 |
| ABBVIE INC. | 2 | $147 |
| GlaxoSmithKline, LLC. | 1 | $125 |
| GENZYME CORPORATION | 1 | $100 |
| SANOFI-AVENTIS U.S. LLC | 1 | $80 |
| Genentech USA, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| UCB, Inc. | 1 | $29 |
Products named: TREMFYA, KEVZARA, PROLIA, RINVOQ, XELJANZ, BENLYSTA, TAVNEOS, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across NY — which companies pay providers there.
